Big Caring Group is heading for a Main Market listing on Bursa Malaysia on 19 Nov, after acquisition-led growth lifted FY2026 revenue to RM4.02 billion and net profit to RM231.8 million. At the retail offer price of RM1.08 per share, the group is valued at around 42 times earnings, while most of the proceeds from the new share issue will be used to repay loans.
Highlights
- Big Caring is targeting a Bursa Malaysia listing at an RM8 billion valuation, with its IPO expected to raise up to RM2.03 billion in gross proceeds.
- RM1.4 billion of the IPO proceeds will go to selling shareholders, while 89.5% of the RM637.8 million in proceeds received by the company will be used to repay loans.
- Big Caring, with 668 outlets and a 24.2% share of Malaysia’s retail pharmacy market in 2025, faces debt management and integration challenges following a series of major acquisitions.
This article was translated from the original. Read the original version by our correspondent here.
IPO details and use of proceeds
As reported by The Edge Malaysia, Big Caring is seeking an RM8 billion valuation through an initial public offering expected to raise up to RM2.03 billion in gross proceeds before any over-allotment option. Of that amount, around RM1.4 billion will go to selling shareholders, while 89.5% of the RM637.8 million in proceeds received by the company will be used to repay loans.The listing is expected to ease the group’s debt burden, but Big Caring’s financial commitments remain substantial due to acquisition-related payments and further expansion plans. The group operates BIG Pharmacy, CARiNG Pharmacy and several other brands, and accounted for an estimated 24.2% of Malaysia’s retail pharmacy market by revenue in 2025, according to Frost & Sullivan.
The offering is set to be one of Malaysia’s largest IPOs this year. Despite its rapid growth, Big Caring’s business has been built through a series of acquisitions that have brought pharmaceutical manufacturing, distribution, retail and healthcare services together under an increasingly integrated group.
Acquisition-led growth and market impact
The group’s roots trace back to a single pharmacy developed alongside co-founder and executive director Lim Sin Yin. After expanding its initial operations, Big Pharmacy merged with RedCap in 2018 in a share-swap transaction that brought private equity firm Creador in as a major shareholder, accelerating expansion beyond the Klang Valley.Big Caring continued its acquisition drive by buying MY Pharmacy Group in 2020, acquiring a 51% stake in Mercury Wellness in 2022, and taking a 70% stake in Ting Pharmacy in 2023. The largest deal was the acquisition of the Caring Pharmacy group for around RM888.3 million in December 2023, adding 256 outlets and bringing Malaysia’s two largest pharmacy brands together under one group.
As of September 2026, the group had grown to 668 outlets. This scale strengthens Big Caring’s position in the local retail pharmacy market, but also means its post-listing performance will continue to be judged by its ability to manage debt, integrate acquired assets and sustain profit growth.
This update follows our previous article on debt restructuring among companies listed on Bursa Malaysia.